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Recent progress in the diagnosis and treatment of coronary
artery disease has intensified the need to differentiate viable
from nonviable myocardium with accuracy and high spatial
resolution. Contrast-enhanced magnetic resonance imaging
(MRI) had been investigated as a potential technique to
assess myocardial viability for several years (1), before the
development of gradient echo-imaging techniques provided
the ability to temporally distinguish perfusion abnormalities
created by microvascular obstruction from myocardial hy-
perenhancement secondary to myocardial necrosis (2,3).
The prognostic value of contrast-enhanced MRI in patients
with acute myocardial infarction (AMI) is well established
(4). However, recent work on the specific utilization of this
technique for the purpose of predicting local functional
recovery after AMI (5,6) has further expanded its potential
utilization in state-of-the-art cardiology practice. The work
by Beek et al. (7) in this issue of the Journal represents an
important addition to our knowledge in this field.
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Beek et al. (7) compared MRI studies performed in the
acute post-infarction phase with similar studies obtained 2
to 4 months later in 30 patients. Of 500 dysfunctional
segments, 273 (55%) improved at follow-up, with little or
no difference in rate of improvement between segments with
no necrosis, compared to those with necrosis involving up to
25% of the left ventricular (LV) wall thickness. As involve-
ment extended across the LV wall, the likelihood of func-
tional recovery diminished, underscoring the power of
contrast-enhanced MRI to quantify transmural necrosis in
patients with AMI. In this regard, Beek et al. (7) indicate
that some degree of recovery can be expected in 20% to 30%
of segments significantly involved by transmural necrosis
(50% of the LV wall), although complete recovery in that
setting occurs much less frequently (5% to 15%). Method-
ologically, the study arrives at these conclusions through
state-of-the-art contrast-enhanced MRI methods coupled
with visual analysis of segmental function, a frequently used
but less objective method to measure segmental function.
On the other hand, the utilization of multilevel logistic
regression analysis to assess the statistical significance of
predicted differences in functional recovery, represents an
advantage over methods that do not adjust for the codepen-
dence of segments at different levels of the typical analysis
tree used in viability studies.
The demonstration of functional recovery in segments
partially involved by necrosis, most frequently at the suben-
docardial level, is important not only from a clinical stand-
point, but also for a more complete understanding of LV
remodeling after myocardial infarction (MI). Although it
first led to questioning the validity of measuring myocardial
necrosis as the extent of MRI delayed hyperenhancement
(8), additional studies documenting the influence of partial
volume effects (9) on the reproducible overestimation of
necrosis by MRI methods (3), have further underscored the
power of contrast-enhanced MRI to discern viable from
nonviable tissue across the LV wall. The development of
improved techniques to amplify the differences between
hyperenhanced necrotic tissue and normal myocardium (10)
has also contributed to the growing clinical incorporation of
these techniques by generating images that are obvious to
the naked eye and preclude offline analyses to determine the
exact boundaries between normal and abnormal tissue
(5–7,9).
Beek et al. (7) demonstrate the relationship between
functional recovery and transmural necrosis using visual
assessment of systolic endocardial motion and wall thicken-
ing. Previous studies used similar methods to document
similar relationships both in the acute (5) and chronic (11)
MI settings. Beek at al. (7) confirmed the low interobserver
variability associated with these methods, particularly when
performed in a before and after setting (late vs. early
post-MI in this case) by trained observers. Ideally, however,
myocardial deformation during systole and diastole would
be objectively quantified to allow for less biased compari-
sons. Unfortunately, planar systolic wall thickening mea-
surements obtained by endocardial and epicardial border
delineation are also quite variable because of technical and
geometric factors intrinsic to LV architecture and function
(12,13). In addition, systolic wall thickening measurements
obtained from border contours do not contain information
on endocardial motion and thus may not be much more
accurate to assess segmental function than visual assessment
performed by well-trained observers. On the other hand,
noninvasive MRI methods to measure myocardial deforma-
tion in multiple orientations (myocardial strains) have been
available for more than a decade (6,13–18), and novel ways
to rapidly acquire and analyze these complex imaging data
sets have been recently developed (6,17,18). Similar meth-
ods using ultrasound to measure myocardial strains in
different directions have also been developed (19), creating
the possibility of a new paradigm for noninvasive objective
functional assessment in the not-so-distant future. It is very
important to realize, however, that all functional indices
based on myocardial deformation (including direct visual
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assessment, wall thickening, and strain measurements) are
load-dependent, and in particular, afterload-dependent.
This load or local stress dependence is even more complex in
the regionally ischemic or infarcted LV, where the mechan-
ical behavior of infarcted subendocardial myocardium is in
large part dictated by that of the preserved subepicardial
layers and vice versa (17,20,21). Similarly, the function of
preserved myocardium adjacent to the infarct border is
heavily dependent on the mechanical behavior of remote
noninfarcted regions (22–24). Load interdependence at
both the global and regional levels is an important factor to
keep in mind when planning and interpreting viability
studies designed to investigate predictors of functional
recovery.
The main mechanism underlying the functional improve-
ment of viable segments after AMI is the resolution of
myocardial stunning in regions that underwent temporary
ischemia but survived owing to either reopening of the
infarct-related artery or reperfusion through collaterals (25).
Myocardial stunning is believed to result from calcium
overload at the time of reperfusion with secondary damage
to contractile proteins of the troponin complex (26). Several
days or sometimes weeks are required to repair the damaged
contractile apparatus, accounting for the typical time course
of functional recovery associated with this condition (5–
7,25,26). However, the mechanistic interpretation of find-
ings from studies performed in patients with chronic isch-
emic heart disease (11,27) is much less obvious. The
pathophysiology of chronically dysfunctional myocardium
has been the subject of intense debate in the past two
decades (27–29), and the mechanisms of functional im-
provement after revascularization in that setting remain
unresolved (27–29). Moreover, in the case of chronic
myocardial dysfunction, the issues related to local functional
interdependence are of even greater importance given that
patient cohorts tend to be less uniform and medical man-
agement less standardized than in the acute setting. Further
investigation on the fundamental mechanisms underlying
functional recovery of “hibernating” myocardium will likely
provide fundamental insights into the pathophysiology of
heart failure due to chronic ischemic myocardial damage.
Today, some of the greatest limitations to the routine use
of contrast-enhanced MRI to assess viability in patients
with ischemic heart disease relate to economic and organi-
zational factors such as cost, easy access to equipment, and
availability of personnel trained to perform and interpret
MRI studies. This is unfortunate because from both the
clinical and scientific perspectives, greater utilization of this
technology by cardiologists and other cardiovascular scien-
tists would be highly desirable. From a clinical perspective,
the available body of literature indicates that contrast-
enhanced MRI can be very useful in patients with AMI and
also in those with chronic LV dysfunction due to ischemic
heart disease. From a scientific standpoint several directions
require further exploration in the quest for a more complete
understanding of myocardial ischemic injury. Among po-
tential directions for further research, the link between
viability and malignant arrhythmias ranks high given the
persistently elevated incidence of sudden death among
patients with ischemic heart disease (30). In this regard,
although extremely useful clinically, currently used tech-
niques to assess myocardial viability may obscure the pres-
ence of “gray areas” corresponding to necrotic tissue inter-
mingled with normal myocardium. The latter limitation
may be of particular importance to investigational efforts
directed at further clarifying the role of border-zone and/or
non-transmural myocardial injury in the genesis of ventric-
ular arrhythmias (31). Future lines of investigation should
also include: 1) further research on microvessel damage and
its role in the ultimate viability of segments injured by
ischemia and reperfusion (32); 2) the development of ionic
distribution maps including sodium (32–35) and eventually
potassium (34) MRI to further probe cellular responses to
ischemia and reperfusion; and 3) the potential to superim-
pose structural myocardial alterations to detailed measure-
ments of function (6,16–18) and metabolism (32–35). The
results accomplished so far, as well as the possible pathways
of discovery that lay ahead, place MRI and spectroscopy at
the forefront of techniques likely to produce future break-
through knowledge on myocardial viability. The paper by
Beek et al. (7) is an important step in the right direction.
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